Anya is a young, agile and innovative publicly listed (TWO: 7776) pharmaceutical company founded in Taipei, Taiwan with offices in India and the United States. Our core mission is to be the authority in oral delivery of peptides. Our patented technology platform Mira/Je® is a flexible solution easy to adapt to a large variety of peptides. Mira/Je® has shown delivery of therapeutic amount in a number of clinical and preclinical studies in a variety of peptides such as teriparatide, leuprorelin, octreotide, semaglutide, liraglutide, tirzepatide and insulin glargine.
Headquarters
4F., No. 3-2, Yuanqu St., Nangang Dist
Taipei City; Taipei City;
Contact Details: Purchase the Anya Biopharm Inc. report to view the information.
Website: http://anyabiopharm.com/tw/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service